EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
21 11-2023

BRAINTEASER Webinar: Women in Multiple Sclerosis

2023-11-21T13:28:27+00:0021-11-2023|

Join us for a online event that focuses on Women in Multiple Sclerosis (MS). This webinar will provide valuable insights and information about the unique challenges and experiences faced by women with MS. Gain knowledge from renowned experts in the field and hear inspiring stories from women who are managing their MS. Don't miss [...]

25 07-2023

Registration now open for the Rethinking Alzheimer’s disease virtual event

2023-09-06T14:45:31+00:0025-07-2023|News|

Registration is now open for the virtual event Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden, taking place virtually on 26 September 2023 at 09:00 – 11:00. The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Swedish Brain Foundation (SBF) and the Swedish Association [...]

13 06-2023

Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden

2023-09-01T15:04:14+00:0013-06-2023|

Registration is now open for the virtual event Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden, taking place virtually on 26 September 2023 at 09:00 – 11:00. The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Swedish Brain Foundation (SBF) and the Swedish Association of [...]

13 06-2023

Save the date launches for Rethinking Alzheimer’s disease virtual event

2023-09-06T14:44:03+00:0013-06-2023|News|

Save the date for the virtual event Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden, set to take place on 26 September 2023 at 10:00 – 12:00 (Brussels time)! About Alzheimer’s disease Alzheimer’s disease (AD) is a neurodegenerative disease that progresses in stages, beginning with a long silent phase [...]

24 11-2022

Save the date for the launch event of the RETHINKING Alzheimer’s disease White Paper!

2023-01-10T13:12:36+00:0024-11-2022|News|

The launch event of the RETHINKING Alzheimer's disease White Paper, calling for change in Alzheimer's care, will take place virtually on 24 January 2023 at 12:30 - 14:00. About Alzheimer's disease Alzheimer’s disease (AD) is a neurodegenerative disease that progresses in stages, beginning with a long silent phase before symptoms occur. It is the underlying cause [...]

10 11-2022

Launch event of the RETHINKING Alzheimer’s disease White Paper

2023-01-11T08:46:20+00:0010-11-2022|

The launch event of the RETHINKING Alzheimer’s disease White Paper, calling for change in Alzheimer’s care, will take place virtually on 24 January 2023 at 12:30 – 14:00. The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), will present its White Paper “RETHINKING Alzheimer’s disease: Detection and diagnosis“. This paper is [...]

23 08-2022

Overcoming roadblocks: Making psychedelic-assisted therapy a reality

2022-08-23T09:47:27+00:0023-08-2022|

Learn about when and how psychedelic-assisted therapy becomes a reality. What are the legislative and regulatory roadblocks, and how Chris Koddermann (ITPRI - Reschedule Psilocybin), Amy Emerson (MAPS PBC), Tadeusz Hawrot (PAREA - Psychedelic Access and Research European Alliance) and Graham Pechenik (Calyx Law) are taking them down? When will psychedelic-assisted therapy become a reality [...]

Go to Top